Diagnos Laboratorium (Indonesia) Market Value
| DGNS Stock | IDR 210.00 6.00 2.78% |
| Symbol | Diagnos |
Diagnos Laboratorium 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Diagnos Laboratorium's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Diagnos Laboratorium.
| 09/17/2024 |
| 12/16/2024 |
If you would invest 0.00 in Diagnos Laboratorium on September 17, 2024 and sell it all today you would earn a total of 0.00 from holding Diagnos Laboratorium Utama or generate 0.0% return on investment in Diagnos Laboratorium over 90 days. Diagnos Laboratorium is related to or competes with Prodia Widyahusada, Medikaloka Hermina, Itama Ranoraya, and Digital Mediatama. PT Diagnos Laboratorium Utama Tbk provides health services using laboratories More
Diagnos Laboratorium Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Diagnos Laboratorium's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Diagnos Laboratorium Utama upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 23.07 | |||
| Value At Risk | (5.45) | |||
| Potential Upside | 6.03 |
Diagnos Laboratorium Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diagnos Laboratorium's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Diagnos Laboratorium's standard deviation. In reality, there are many statistical measures that can use Diagnos Laboratorium historical prices to predict the future Diagnos Laboratorium's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | 0.4081 |
Diagnos Laboratorium Backtested Returns
Diagnos Laboratorium secures Sharpe Ratio (or Efficiency) of -0.12, which denotes the company had a -0.12% return per unit of standard deviation over the last 3 months. Diagnos Laboratorium Utama exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Diagnos Laboratorium's Standard Deviation of 3.52, coefficient of variation of (786.37), and Mean Deviation of 2.43 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.12, which means a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Diagnos Laboratorium are expected to decrease slowly. On the other hand, during market turmoil, Diagnos Laboratorium is expected to outperform it slightly. At this point, Diagnos Laboratorium has a negative expected return of -0.44%. Please make sure to confirm Diagnos Laboratorium's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Diagnos Laboratorium performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Diagnos Laboratorium Utama has good predictability. Overlapping area represents the amount of predictability between Diagnos Laboratorium time series from 17th of September 2024 to 1st of November 2024 and 1st of November 2024 to 16th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Diagnos Laboratorium price movement. The serial correlation of 0.76 indicates that around 76.0% of current Diagnos Laboratorium price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 85.54 |
Diagnos Laboratorium lagged returns against current returns
Autocorrelation, which is Diagnos Laboratorium stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Diagnos Laboratorium's stock expected returns. We can calculate the autocorrelation of Diagnos Laboratorium returns to help us make a trade decision. For example, suppose you find that Diagnos Laboratorium has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Diagnos Laboratorium regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Diagnos Laboratorium stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Diagnos Laboratorium stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Diagnos Laboratorium stock over time.
Current vs Lagged Prices |
| Timeline |
Diagnos Laboratorium Lagged Returns
When evaluating Diagnos Laboratorium's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Diagnos Laboratorium stock have on its future price. Diagnos Laboratorium autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Diagnos Laboratorium autocorrelation shows the relationship between Diagnos Laboratorium stock current value and its past values and can show if there is a momentum factor associated with investing in Diagnos Laboratorium Utama.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.